<DOC>
	<DOCNO>NCT01513044</DOCNO>
	<brief_summary>An open-label , balance , randomize , two-treatment , two-period , two sequence , single dose , crossover , bioequivalence study Mycophenolate mofetil 250 mg Capsule Dr. Reddy 's Laboratories limit , compare Cellcept 250 mg Capsule Roche Laboratories healthy , adult , human , male subject fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Mycophenolate Mofetil 250 mg Capsule , Under Fasting Conditions</brief_title>
	<detailed_description>This open-label , balance , randomize , two-treatment , two-sequence , two-period , single dose , crossover bioequivalence study healthy , adult , human , male subject Fasting condition . 72 healthy male adult enrol . A washout period 7 day maintain successive dose days.One capsule contain mycophenolate mofetil 250 mg administer orally 240 mL water sit posture , overnight fast least 10 hour period . This activity follow mouth check ass compliance dosing . The subject allow lie first two hour dose .</detailed_description>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Subjects age 18 50 year ( include ) . Subjects ' weight within normal range accord normal value Body Mass Index ( 1 8.5 24.9 kg/m2 ) minimum 50 kg weight . Subjects clinically acceptable normal health determine personal medical history , clinical examination laboratory examination within clinically acceptable reference range . Subjects clinically acceptable 12lead electrocardiogram ( ECG ) . Subjects clinically acceptable chest XRay ( PIA view ) . Subjects negative urine screen drug abuse ( include amphetamine , barbiturate , benzodiazepine , marijuana , cocaine , morphine ) . Subjects negative alcohol breath test . Subjects willing adhere protocol requirement provide write informed consent . The subject exclude study , meet follow criterion : Hypersensitivity Mycophenolate Mofetil relate drug . History presence significant cardiovascular , pulmonary , hepatic , renal , gastrointestinal , endocrine , immunological , dermatological , neurological psychiatric disease disorder . History presence significant alcoholism drug abuse past one year . History presence significant smoking ( 10 cigarette day consumption tobacco product ) . History presence asthma , urticaria significant allergic reaction . History presence significant gastric and/or duodenal ulceration . History presence glaucoma , prostatic hypertrophy obstruction bladder neck , cardiospasm myasthenia gravis . History presence significant thyroid disease , adrenal dysfunction , organic intracranial lesion pituitary tumor . History presence cancer . Difficulty donate blood . Difficulty swallow solid like tablet capsule . Use prescribed medication OTC medicinal product last two week prior initiation study . Major illness 3 month screen . Participation drug research study within past 3 month . Donation blood past 3 month screen . Positive screen test one : HIV , Hepatitis B Hepatitis C. History presence significant easy bruise bleeding . History presence significant recent trauma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>Mycophenolate Mofetil</keyword>
	<keyword>crossover</keyword>
</DOC>